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Natural killer (NK) cells are able to recognize and kill tumor cells, however whether they con-
tribute to tumor immunosurveillance is still debated. Our previous studies demonstrated
the presence of NK cells in human lung tumors. Their comparison with NK cells from
non-tumoral lung tissues and with blood NK cells from the same individuals revealed a
decreased expression of some NK receptors and impaired ex vivo cytotoxic functions
occurring specifically in NK cells isolated from the tumor microenvironment. The aim of
the present study was to characterize the transcriptional profile of such intratumoral NK
cells, by comparative microarray analysis of sorted NK cells isolated from non-tumoral (Non-
Tum-NK) and tumoral (Tum-NK) lung tissues of 12 Non-Small Cell Lung Cancer patients. Our
results reveal a specific gene expression signature ofTum-NK cells particularly in activation
processes and cytotoxicity, confirming that tumor environment induces modifications in
NK cells biology. Indeed, intratumoral NK cells display higher expression levels of NKp44,
NKG2A, Granzymes A and K, and Fas mRNA. A particular pattern of receptors involved in
chemotaxis was also observed, with an overexpression of CXCR5 and CXCR6, and a lower
expression of CX3CR1 and S1PR1 genes in Tum-NK as compared to Non-Tum-NK cells.
The precise identification of the molecular pathways modulated in the tumor environment
will help to decipher the role of NK cells in tumor immunosurveillance and will open future
investigations to manipulate their antitumoral functions.
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INTRODUCTION
Among the actors of antitumor immunity, Natural Killer (NK)
cells are innate immune cells specialized in recognition and killing
of tumor cells, since they have the ability to distinguish normal
cells from tumor cells (Vivier et al., 2012). This tumor cell recog-
nition process by NK cells is controlled by an array of activating
and inhibitory receptors, which enable NK cells to detect and then
kill their cellular targets.
Several experimental evidences demonstrated the important
role of NK cells in the elimination of tumor cells. A low
NK cell cytotoxicity in peripheral blood was correlated with
an increased cancer risk (Vivier et al., 2012). In addition, the
presence of tumor infiltrating NK cells, determined as CD57+
cells, was associated with good prognosis in colorectal (Coca
et al., 1997), gastric (Ishigami et al., 2000), and lung (Ville-
gas et al., 2002) cancers. However, recent studies conducted on
NK cells from lung, breast cancer, melanoma, and gastrointesti-
nal stromal tumors indicated that their phenotype and func-
tions were largely altered, resulting in an impaired ability of
NK cells to kill tumoral cells ex vivo (Delahaye et al., 2011;
Mamessier et al., 2011; Platonova et al., 2011; Pietra et al.,
2012).
We previously observed that NK cells are enriched in the tumor
microenvironment and mainly localized in the tumor stroma of
early stages Non-Small Cell Lung Carcinoma (NSCLC; Platonova
et al., 2011). Phenotypic and functional analysis of these intratu-
moral NK cells showed a decreased expression of NK cell recep-
tors, including NKp30, NKp80, DNAM-1, CD16 and ILT-2, and
impaired capacities of degranulation. Interestingly, these altered
phenotype and functions were specifically observed in NK cells
isolated from the tumor, but neither in NK cells from distant lung
tissue or blood from the same patient, and nor in NK cells isolated
from other lung pathologies, such as emphysema and bronchial
dilatation (Platonova et al., 2011). These results emphasize that
the tumor microenvironment induces biological modifications of
NK cells, that could be related to different mechanisms, such as
down-regulation of NK receptors after target cell recognition and
interaction, or their cleavage by metalloproteases released in the
tumor microenvironment. Another hypothesis is that NK cells,
after being recruited in the tumoral site, could sustain a particular
program of differentiation, leading to a distinct phenotype.
Here, we therefore characterized intratumoral NK cells at the
mRNA level, and compared the gene expression profile of NK
cells sorted from the tumors to that of NK cells sorted from the
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non-tumoral lung of 12 patients, by microarray analysis. This is
the first study investigating gene expression of human NK cells
isolated from a solid tumor tissue and its non-tumoral coun-
terpart, thus allowing the characterization of NK cells inside
their tumor microenvironment. We demonstrate that, among the
42,405 probes representing the whole genome, 1236 genes are
differentially expressed, with 792 genes up-regulated, and 444
down-regulated in intratumoral NK cells, indicating a specific
transcriptional signature induced by the tumor environment.
RESULTS
NSCLC PATIENTS AND NK CELL SORTING
The 12 NSCLC patients (stages IB–IIIA) enrolled in this study
were smokers and did not receive neo-adjuvant chemotherapy.
Among these patients, seven had adenocarcinoma (ADC) and five
squamous cell carcinoma (SCC; Table 1).
For each patient, NK cell were sorted from tumoral and
non-tumoral distant tissue, using the specific immunostaining
Table 1 | Clinical characteristics of NSCLC patients.
Patient Age Sex Tobacco (PY) Histology Stage (2009)
P1 61 M 45 ADC IB
P2 62 F 50 ADC IB
P3 59 F >10 ADC IB
P4 72 F 60 ADC IB
P5 78 F 50 ADC IB
P6 60 M 50 ADC IIA
P7 61 M 50 ADC IIIA
P8 71 F 40 SCC IB
P9 57 M 80 SCC IB
P10 79 M 50 SCC IIB
P11 80 M 40 SCC IIB
P12 84 M >10 SCC IIIA
Pathological staging and histological types of the tumorswere determined accord-
ing to the 2009 TNM staging system and World Health Organization. PY, packs
per year; ADC, adenocarcinoma; SCC, squamous cell carcinoma.
CD3−CD56+ (Figure 1). Sorted populations containing more
than 95% CD3−CD56+ cells were considered acceptable to include
the sample in the study. Total RNA from Non-Tum-NK and
Tum-NK cells was used to analyze whole genome expression by
microarray experiments.
GENOME-WIDE EXPRESSION COMPARISON BETWEEN
INTRATUMORAL AND NON-TUMORAL NK CELLS
Previous studies showed that NK cell phenotype and functions
were altered in human lung tumors (Platonova et al., 2011). Gene
expression profiling using Agilent microarray technology was per-
formed to characterize the transcriptional signature of Tum-NK
and Non-Tum-NK cells. Normalized signal values correspond-
ing to the 42,405 probe-sets representing the whole genome were
imported from microarrays data files. Probes (35,120) giving nor-
malized signal values different from the background signal in at
least half of the chips involved in the study were selected.
To determine whether Tum-NK cells displayed a specific
transcriptomic signature, a non-supervised clustering analysis
(Spearman correlation similarity measure and ward linkage algo-
rithm) with the normalized signal values of the 35,120 probe-sets
was performed (Figure 2A). Interestingly, a clear good delin-
eation between the Tum-NK and Non-Tum-NK cell samples was
observed, independently of the patient, except for two of them
(Patients 3 and 7).
Based on these results, an unpaired supervised clustering was
generated including probes showing a minimal twofold-change
expression between Tum-NK and Non-Tum-NK cells, with a min-
imal p-value of 0.05. Using these filters, a list of 1236 genes that
were differentially and significantly expressed between Tum-NK
and Non-Tum-NK cells was obtained (Figure 2B). A perfect
delineation between the Tum-NK and Non-Tum-NK cells was
observed. However, there was no clustering of the patients based
on smoking status, histological, or stage of the tumor, demonstrat-
ing that Tum-NK cells have a distinct gene expression signature
compared to Non-Tum-NK cells.
To emphasize this observation, a heat map including the 1236
genes differentially expressed between the two groups of NK
cells (fold-change >2, p-value< 0.05) was built (Figure 3A). All
A B
FIGURE 1 | Cell sorting of NK cells from NSCLC tissues. CD3−CD56+ NK cells were sorted from non-tumoral and tumoral tissues for each patient. Cell
surface expression was monitored by flow cytometry before (A) and after the cell sorting (B) to check the purity.
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A B
FIGURE 2 | Clustering analysis on gene expression. (A) After
normalization, probes for which fluorescence values were significantly
different from the background signals in at least half of the arrays
involved in the study were selected (35,120 probes among the total of
42,405 probe-sets). Unsupervised hierarchical clustering based on the
35,120 probes was performed. (B) Supervised and unpaired hierarchical
clustering was performed based on the 1236 probes that appeared
differentially expressed between the Tum-NK and the Non-Tum-NK cells
using as filter a minimal twofold-change in expression with
p-value<0.05.
Non-Tum-NK cells samples are clustered in homogenous manner
on the upper part of the map, and Tum-NK cells on the down part.
A volcano plot showing gene expression variation in Tum-NK cells
compared to Non-Tum-NK cells revealed a set of 792 genes that
were up-regulated and 444 genes down-regulated in Tum-NK cells
(fold-change >2, p< 0.05; Figure 3B).
Taken together, these results clearly demonstrated that NK cells
sorted from lung tumors display a specific gene expression signa-
ture, different from that of NK cells sorted from the non-tumoral
lungs.
INTRATUMORAL NK CELLS DISPLAY GENE EXPRESSION SIGNATURE OF
ACTIVATED CELLS
To determine the immunological meaning of this gene expression
profile, the most relevant functions related to genes modulated
in Tum-NK were characterized using Ingenuity Pathway Analysis
(IPA) application.
Among the 1236 genes, 871 unique and predicted genes were
successfully mapped to a gene in Ingenuity Pathways Knowledge
Base (IPKB). Networks were then generated from these 871 genes
to determine the associated functions including immune cell traf-
ficking and inflammatory responses. The IPA software was used
to assort the corresponding list of the top immunological func-
tions based on the number of genes implicated and the p-value
attributed to the variation of each gene expression (Table 2).
The top functions found modulated in Tum-NK cells as com-
pared to Non-Tum-NK cells included mainly movement and acti-
vation of leukocytes. Focusing the analysis on NK cell functions,
cytotoxicity also appeared as highly significant. Indeed, intratu-
moral NK cells display a high gene expression of NKp44, a marker
that has been demonstrated as an NK cell activation marker (Vitale
et al., 1998), according to the overexpression observed by FACS
analysis in our previous study, and an increased expression of cyto-
toxic molecules, such as Granzymes A and K and Fas, compared
to NK cells from normal lung tissue. On the contrary, we observed
only a slight decreased expression of NKp30, NKp80, DNAM, and
CD16 on Tum-NK cells, in contrast with the strong decrease of
cell surface expression of these molecules (Platonova et al., 2011).
Finally, intratumoral NK cells displayed a specific modulation of
gene expression of receptors involved in cell migration, as indi-
cated by the down-regulation of CX3CR1 and S1PR1 and the
up-regulation of CXCR5 and CXCR6 receptors (Table 3).
Altogether, these data indicate that intratumoral NK cells after
being recruited in the tumor site, display markers of activation and
cytotoxicity.
DISCUSSION
This study revealed transcriptional modulations occurring specif-
ically in NK cells present in NSCLC tumor environment, with
particular gene expression signature. These observations are in
agreement with our previous observations demonstrating that
lung tumor microenvironment induces modifications in NK cells
biology.
Several hypothesis could explain the phenotypic and functional
alterations of Tum-NK cells. It could reflect that NK cells enter in
a particular transcriptional program in the tumor environment or
that the recognition of tumor target cells induces these changes.
The cleavage of the NK receptors by metalloproteases, or their
down-regulation by secreted factors such as IDO and cytokines
could represent some of these mechanisms (Mamessier et al.,
2011).
In the present microarray analysis, comparing gene expression
profile of NK cells sorted from tumoral and non-tumoral lung
tissues, we observed only a slight modulation of NKp30, NKp80,
CD16, DNAM-1, and ILT-2 at the transcriptional level. This sug-
gests that the low expression of these receptors,which was observed
by flow cytometry analysis, was not a result of a particular program
of NK cell differentiation induced by the tumor. Therefore investi-
gations have now to be performed to characterize the mechanisms
leading to modification of phenotype and functions of NK cells.

























































Gillard-Bocquet et al. Intratumoral lung NK cell transcriptome
FIGURE 3 | Differences in genome-wide expression betweenTum-NK
cells and Non-Tum-NK cells. (A). Hierarchical clustering of the 1236
differentially expressed genes in Tum-NK cells compared to Non-Tum-NK cells.
Individual patients are oriented in rows and expression level for each gene is
oriented in columns. Red, green, and black colors of the heat map represent
the expression levels that are greater than, equal to, or less than the mean
expression levels, respectively, in all samples. (B) Volcano plot comparison of
differentially expressed genes between Tum-NK cells vs. Non-Tum-NK cells.
Genes are arranged along dimensions of biological and statistical significance.
The horizontal dimension is the variation of gene expression [log2 (ratio)]
between the two groups, and the vertical axis represents the p-value. In red
and orange are represented genes that are over-expressed in Tum-NK cells,
with a fold-change superior to 2 (792 genes) and comprised between 1.5 and
2 (556 genes), respectively. In green and dark green are represented genes
that are under-expressed in Tum-NK cells, with a fold-change superior to 2
(444 genes) and comprised between 1.5 and 2 (629 genes), respectively.
We identified biological functions associated to modulated genes
in Tum-NK cells compared to Non-Tum-NK cells, including acti-
vation, cytotoxicity, and leukocyte movement. Among genes that
were over-expressed in intratumoral NK cells, we found the NK cell
activation marker NKp44, Granzymes A and K, and Fas, which are
involved in cytotoxicity, and CXCR5 and CXCR6, two chemokine
receptors whose expression has been previously described in few
studies in some NK cell subpopulations, such as memory (Paust
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Table 2 | Functions modulated inTum-NK cells.
Functions p-Value
Cell movement of leukocytes 3.81E−09
Activation of leukocytes 8.53E−06
Cell movement of natural killer cells 3.55E−06
Activation of natural killer cells 4.12E−08
Cytotoxicity of natural killer cells 2.21E−08
Table 3 | Specific genes modulated inTum-NK cells.
Genes Fold-change expression* p-Value
NCR1 (NKp46) −1.24 3.28E−01
NCR2 (NKp44) +28.65 7.91E−04
NCR3 (NKp30) −1.12 8.53E−06
KLRF-1 (NKp80) −1.8 8.44E−03











*Fold-change expression calculated between expression inTum-NK vs. Non-Tum-
NK.
et al., 2010) or activated NK cells (Berahovich et al., 2006; Dybkaer
et al., 2007).
Therefore, this study strongly suggests that NK cells after being
recruited in the tumor, become activated and finally exhausted,
after target cell recognition. We hypothesize that NK cells may
downregulate some receptors at the surface level but not at the
transcriptional level as a consequence of such activation, by a
mechanism dependent of the tumor environment (Platonova
et al., 2011; Cremer et al., 2012). Further investigations will help
to define more precisely the genes involved in such functions at
the molecular as well as functional levels. Indeed, the precise iden-
tification of the molecular functions and pathways modulated in
tumor environment will help to decipher the role of NK cells in
the control of lung tumors and will open future investigations to
manipulate their antitumoral functions.
MATERIALS AND METHODS
TISSUE SAMPLES FROM NSCLC PATIENTS
Human primary NSCLC samples and non-tumoral distant tis-
sues (situated at >10 cm from the tumor) were obtained from
non-treated patients, the day of surgery, at Institut Mutualiste
Montsouris (Paris) or Hotel Dieu hospital (Paris). All the patients
gave an informed consent. The study was conducted with the
agreement of the french ethic comity (number 2008-133) in
application with the article L. 1121-1 of french law.
PREPARATION OF HUMAN SINGLE-CELL SUSPENSION AND NK CELL
SORTING
Surgical samples were mechanically dilacerated, and single-cell
suspensions obtained after enzymatic disruption using collagenase
and DNAse for 1 h at 37˚C under magnetic agitation in serum-
free RPMI1640 RPMI +1% penicillin-streptomycin were filtered
through a 0.7µm cell strainer (BD Biosciences). Cells were washed
in PBS+ 5% FCS+ EDTA 0.5 mM and mononuclear cells were
purified using Ficoll gradient.
Mononuclear cells were incubated with fluorescein isothio-
cyanate – conjugated anti-CD3 (mIgG1κ, clone UCHT1, BD
Pharmingen), phycoerythrin-conjugated anti-CD45 (mIgG1κ,
clone J.33, Beckman Coulter), and allophycocyanin – conjugated
anti-CD56 (mIgG2bκ, clone N-CAM16.2, BD Pharmingen) for
20 min at 4˚C and analyzed with a FACSAria III cell sorter (BD
Biosciences).
Flow cytometry data were analyzed using Cellquest Pro soft-
ware (BD Biosciences). NK cells were defined as CD3−CD56+
cells and sorted in the lysis buffer supplied in the RNA extraction
Kit. The purity for the sorted samples was at least 95%. Depending
on samples, the number of sorted NK cells ranged between 11,500
and 84,500.
ISOLATION OF TOTAL RNA FROM NK CELLS
Total RNA was extracted with the RNEasy Micro Kit (Qiagen)
according to manufacturer’s instructions. RNA quality and quan-
tity were analyzed on a PicoChip (Total Eukaryote RNA Assay Pico
II Kit, Qiagen) by capillary electrophoresis (BioAnalyzer; Agilent).
Samples with a RNA Integrity Number (RIN)≥7 were considered
suitable for microarray experiments.
MICROARRAY EXPERIMENTS
For the generation of amplified cDNA (SuperAmp Service, Mil-
tenyi Biotec), the mRNA was extracted from the total RNA samples
(5 ng) using magnetic beads and transcribed into cDNA using
tagged random and oligo(dT) primer. First strand cDNA was 5′
tagged using 8 U terminal deoxynucleotidyl transferase (Fermen-
tas) and incubating for 60 min at 37˚C before heat inactivating
at 70˚C for 5 min. Tagged cDNA was globally amplified (Expand
Long Template PCR System DNA Pol Mix, Roche) using primer
complementary to the tag sequence and incubating at 78˚C for
30 s, 20 cycles of 94˚C for 15 s, 65˚C for 30 s, and 68˚C for 2 min
followed by 21 cycles of 94˚C for 15 s, 65˚C for 30 s, and 68˚C
for 2.5 min with an extension of 10 s/cycle and a final step of
68˚C for 10 min. PCR product was purified (NucleoSpin®Extract
II, Macherey-Nagel) and cDNA yield measured. About 250 ng of
purified PCR product was labeled with Cy3-dCTP (Amersham)
in a Klenow Fragment (10 U) reaction for 1:50 h at 37˚C before
inactivating through addition of 5µl 0.5 M EDTA pH 8.0. About
0.5µg Cy3-labeled and purified (Cy-Scribe GFX Purification Kit,
GE Healthcare) cDNAs were used for each microarray analysis.
HYBRIDIZATION OF AGILENT WHOLE HUMAN GENOME OLIGO
MICROARRAYS
The hybridization procedure was performed according to the
One-Color Microarray-Based Gene Expression Analysis proto-
col (version 6.5, part number G4140-90040) using the Agilent
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Gene Expression Hybridization Kit (Agilent Technologies). Briefly,
0.5µg Cy3-labeled cDNA in hybridization buffer was hybridized
overnight (17 h, 65˚C) to Agilent Whole Human Genome Oligo
Microarrays 8 K× 60 K using Agilent’s recommended hybridiza-
tion chamber and oven. Following hybridization, the microar-
rays were washed once with the Agilent Gene Expression Wash
Buffer 1 for 1 min at room temperature followed by a second
wash with preheated Agilent Gene Expression Wash Buffer 2
(37˚C) for 1 min. The last washing step was performed with
acetonitrile.
SCANNING AND DATA ANALYSIS
Fluorescence signals of the hybridized Agilent Microarrays were
detected using Agilent’s Microarray Scanner System (Agilent Tech-
nologies). The Agilent Feature Extraction Software (FES) 10.7.3.1
was used to read out and process the microarray image files. For
determination of differential gene expression FES derived output
data files were further analyzed using the Rosetta Resolver gene
expression data analysis system (Rosetta Biosoftware, Rosetta error
model; Weng et al., 2006).
STATISTICAL AND DATA ANALYSIS
For each probe, the ratio of the average of fluorescence inten-
sity (fold-change) was calculated for the Tum-NK related to the
Non-Tum-NK samples.
A “P50” list has been created by filtering probes flagged as
“Present” for at least half of the chips involved in the study, and
was used for the genome comparison. The group comparisons
were done using Student’s t -test. To estimate the false discovery
rate the resulting p-values we filtered at 0.05. Cluster analysis
was performed by hierarchical clustering, using the Spearman
correlation similarity measure and ward linkage algorithm.
An unsupervised analysis step was performed using clustering
prior to any supervised statistical comparison to unveil natural
groups among the tested samples.
Probes lists were filtered by p-value< 0.05 reflecting the statis-
tical validity and by twofold-change variation of the gene expres-
sion. A new clustering step was performed after supervised analysis
in order to test the generated list by classifying the samples in
expected groups.
To visualize the gene expression we turn mean centered data
into heatmaps built by hierarchical classification using the Spear-
man correlation similarity measure and ward linkage in clustering
algorithm. The data were computed with R and the graphic pro-
duced with TreeView. A volcano plot was constructed for each
comparison results by plotting the negative log of the p-value on
the y-axis and the x-axis is the log of the fold-change between the
two conditions.
Data were subsequently used for Ingenuity Pathway Analysis
(IPA) to model relationships among genes and proteins and to
determine putative relevant biological processes.
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